Public-private partnerships in health sector innovation: Lessons from around the world
1 University of North Florida, USA.
2 Pediatric Clinic, William. D Kelley School Dental Clinic, Kornberg School of Dentistry, Temple University, USA.
3 Health information analyst, Huntington, WV, U.S.A.
4 Marshall University, USA.
5 Public Health Specialist; United Kingdom.
Review Article
Magna Scientia Advanced Biology and Pharmacy, 2024, 12(01), 045–059
Publication history:
Received on 09 April 2024; revised on 21 May 2024; accepted on 24 May 2024
Abstract:
Public-Private Partnerships (PPPs) have emerged as a crucial mechanism for fostering innovation in the health sector globally. This review encapsulates the lessons learned from diverse PPP models worldwide, highlighting their significance and impact. PPPs in healthcare innovation entail collaboration between governmental bodies, private enterprises, and sometimes non-profit organizations to address challenges, such as limited resources, expertise, and infrastructure, while leveraging the strengths of each sector. The success of PPPs relies on effective governance structures, clear objectives, and mutual accountability. One notable example is the United Kingdom's NHS Innovation Accelerator, which partners with industry leaders to fast-track the adoption of innovative healthcare technologies within the National Health Service (NHS). Through this initiative, pioneering solutions, ranging from digital health platforms to medical devices, have been implemented, enhancing patient care and operational efficiency. Similarly, in low-resource settings like sub-Saharan Africa, PPPs have played a pivotal role in improving access to essential healthcare services. Projects such as the Medicines for Malaria Venture (MMV) collaborate with pharmaceutical companies, governments, and research institutions to develop affordable antimalarial drugs tailored to the region's needs. In the realm of medical research and development, partnerships like the Coalition for Epidemic Preparedness Innovations (CEPI) have demonstrated the power of international collaboration in addressing global health threats. CEPI brings together governments, philanthropic organizations, and the private sector to expedite the development of vaccines against emerging infectious diseases, as witnessed during the COVID-19 pandemic. However, challenges persist in PPP implementation, including complex regulatory frameworks, funding uncertainties, and divergent interests among stakeholders. Lessons from successful PPPs underscore the importance of transparent communication, stakeholder engagement, and sustained political commitment. In conclusion, PPPs in the health sector represent a dynamic avenue for catalyzing innovation and driving transformative change. By drawing insights from diverse experiences worldwide, policymakers and practitioners can refine existing frameworks and foster sustainable partnerships to tackle evolving health challenges effectively.
Keywords:
Public-Private Partnership; Health; Innovation; World; Review
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0